Femular (Ze 450) is a tablet containing extracts equivalent to dry Cimicifuga racemosa rhizome 42,25 mg.
It is manufactured in Switzerland by Zeller, a herbal medicine company with 135 years of involvement in the research and production of natural medicines.
Femular is used in the treatment of menopausal symptoms, such as:
The safety and efficacy of Femular have been confirmed by clinical trials conducted in Germany. Femular has no oestrogenic effect.
The dosage of Femular is one tablet daily. The onset of action can be expected within 2 to 4 weeks, with a maximal effect after 3 months. There is no restriction on the duration of treatment. The daily dose can be incrased to 2 tablets if necessary.
705994-001
R 99,70 (incl.VAT)
Always read the label. Use only as directed. If symptoms persist, patients should consult their health care professional.